In recent trading session, Sanofi ADR (NASDAQ:SNY) saw 2.05 million shares changing hands at last check today with its beta currently measuring 0.58. Company’s recent per share price level of $48.95 trading at -$1.08 or -2.16% at last check today assigns it a market valuation of $122.51B. That closing price of SNY’s stock is at a discount of -14.26% from its 52-week high price of $55.93 and is indicating a premium of 12.91% from its 52-week low price of $42.63. Taking a look at company’s average trading volume volume of 2.09 million if we extend that period to 3-months.
Sanofi ADR (NASDAQ:SNY) trade information
Upright in the red during last session for losing -2.16%, in the last five days SNY remained trading in the red while hitting it’s week-highest on Wednesday, 05/01/24 when the stock touched $48.95 price level, adding 2.82% to its value on the day. Sanofi ADR’s shares saw a change of -1.57% in year-to-date performance and have moved -0.83% in past 5-day. Sanofi ADR (NASDAQ:SNY) showed a performance of 2.06% in past 30-days.
Sanofi ADR (SNY) estimates and forecasts
Statistics highlight that Sanofi ADR is scoring comparatively lower than the scores of other players of the relevant industry. The company added 8.18% of value to its shares in past 6 months, showing an annual growth rate of -6.15% while that of industry is 4.40. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 8.00% from the last financial year’s standing.
5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 11.22B for the same. And 5 analysts are in estimates of company making revenue of 13.86B in the next quarter. Company posted 11.23B and 12.63B of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 2.68% during past 5 years. In 2024, company’s earnings growth rate is likely to be around -6.15% while estimates for its earnings growth in next 5 years are of 9.00%.
SNY Dividends
Sanofi ADR is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
